Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response-Reference-Cited by-同舟云学术

Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response

Published:2017-11-16 Issue:1 Volume:66 Page:200-206
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Arab Atefeh,Nicastro Jessica,Slavcev Roderick,Razazan Atefeh,Barati Nastaran,Nikpoor Amin Reza,Brojeni Amir Abbas Momtazi,Mosaffa Fatemeh,Badiee Ali,Jaafari Mahmoud Reza,Behravan Javad

Funder

Mashhad University of Medical Sciences (MUMS) to JB and NSERC to RS and JN.

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/article/10.1007/s12026-017-8969-0/fulltext.html

Reference36 articles.

1. Vergati M, Intrivici C, Huen NY, Schlom J, Tsang KY. Strategies for cancer vaccine development. J Biomed Biotechnol. 2010;1–13. https://doi.org/10.1155/2010/596432 .

2. Hubbell JA, Thomas SN, Swartz MA. Materials engineering for immunomodulation. Nature. 2009;462(7272):449–60.

3. Bramwell VW, Perrie Y. Particulate delivery systems for vaccines. Crit Rev Ther Drug Carrier Syst. 2005;22(2):151–214.

4. Prisco A, De Berardinis P. Filamentous bacteriophage fd as an antigen delivery system in vaccination. Int J Mol Sci. 2012;13(4):5179–94.

5. Plummer EM, Manchester M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev: Nanomedicine Nanobiotechnology. 2011;3(2):174–96.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering customized nanovaccines for enhanced cancer immunotherapy;Bioactive Materials;2024-06

2. Improving Pharmacokinetics of Peptides Using Phage Display;Viruses;2024-04-07

3. An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy;Viruses;2024-02-01

4. New role of bacteriophages in medical oncology;Biotechnology and Applied Biochemistry;2023-08-28

5. Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy;International Journal of Molecular Sciences;2023-08-19